作者的详细信息
Antsiferova, D. M.
| 期 | 栏目 | 标题 | 文件 |
| 卷 30, 编号 12 (2023) | Pharmacological properties of drugs | Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution | |
| 卷 31, 编号 2 (2024) | Clinical experience | Modern technologies in diabetes management | |
| 卷 31, 编号 2 (2024) | Original articles | The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow | |
| 卷 31, 编号 8 (2024) | New drugs and treatment approaches | Current trends in self-monitoring of glycemic levels | |
| 卷 31, 编号 8 (2024) | Original articles | Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data) |